Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazrek

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annales De Biologie Clinique|December 7, 2005
[Various approaches of therapeutic vaccination for the treatment of HIV type 1 infection]M Lazrek, P E Lobert, A Goffard, et al.
Annales De Biologie Clinique|March 25, 2006
[Fatal fulminant Epstein-Barr virus hepatitis]M Lazrek, F Boitrelle, A Dewilde, et al.
Journal of Viral Hepatitis|May 22, 2009
A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective studyP Deltenre, V Canva, M El Nady, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2011
Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategyP Deltenre, C Moreno, A Tran, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 26, 2017
Predominance of G9P[8] rotavirus strains throughout France, 2014-2017J Kaplon, N Grangier, S Pillet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 12, 2016
Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in FranceA de Rougemont, J Kaplon, C Fremy, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annales De Biologie Clinique|December 7, 2005
[Various approaches of therapeutic vaccination for the treatment of HIV type 1 infection]M Lazrek, P E Lobert, A Goffard, et al.
Annales De Biologie Clinique|March 25, 2006
[Fatal fulminant Epstein-Barr virus hepatitis]M Lazrek, F Boitrelle, A Dewilde, et al.
Journal of Viral Hepatitis|May 22, 2009
A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective studyP Deltenre, V Canva, M El Nady, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2011
Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategyP Deltenre, C Moreno, A Tran, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 26, 2017
Predominance of G9P[8] rotavirus strains throughout France, 2014-2017J Kaplon, N Grangier, S Pillet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 12, 2016
Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in FranceA de Rougemont, J Kaplon, C Fremy, et al.
Pageof 2